查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1226743

細胞增生套件的全球市場:現狀分析與預測(2022年～2028年)

Cell Proliferation Kit Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球細胞增生套件的市場規模，在預測期間內預計以約7％的年複合成長率成長。癌症和腫瘤的患者數增加，早期診斷增加，為了減輕醫療費負擔的政府配合措施增加，醫療的認識高漲，促進市場成長。

本報告提供全球細胞增生套件市場的相關調查，市場洞察，市場趨勢，競爭模式，企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 主要的目標
  • 相關利益者
  • 限制

第2章 調查手法或假設

  • 細胞增生套件市場調查流程
  • 細胞增生套件市場調查手法
  • 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對細胞增生套件市場的影響

第6章 全球細胞增生套件市場收益(2022年～2028年)

第7章 市場洞察:各類型

  • 螢光細胞生存套件
  • 比色細胞生存套件
  • 生物冷光細胞生存套件
  • 其他

第8章 市場洞察:各用途

  • 製藥、生物科技企業
  • 學術、研究機關
  • 其他

第9章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他的北美
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他的亞太地區
  • 其他

第10章 細胞增生套件的市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 細胞增生套件的市場機會

第12章 細胞增生套件的市場趨勢洞察

第13章 需求面和供給方面的分析

  • 需求面分析
  • 供給面

第14章 價值鏈分析

第15章 價格分析

第16章 策略性洞察能力

第17章 競爭模式

  • 競爭情形
    • 波特的五力分析

第18章 企業概要

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • GE Healthcare
  • PerkinElmer Inc
  • Bio-Rad Laboratories, Inc.
  • Becton Dickinson and Co
  • Biotium
  • Agilent Technologies Inc
  • F. Hoffmann-La Roche AG
  • Biological Industries

第19章 免責聲明

簡介目錄
Product Code: UMME211630

The cell proliferation kit market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Cell replication, or the process of cell proliferation, is essential for maintaining the homeostasis of adult tissues by replacing dead cells with fresh ones. This process begins during embryogenesis. Abnormal cell proliferation is seen in a few disease conditions, such as cancer. So, in both in vitro and in vivo settings, cell proliferation assay kits gained popularity in the clinical diagnosis of various disease indications. These are used in research studies of cell activation, cytotoxicity assessment, and clinical trials to determine therapeutic efficacy. The growing demand for cell proliferation kits can be attributed to the rising numbers of patients with cancer and tumors across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for cell proliferation kits across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the cell proliferation kit market is anticipated to grow on account of the increasing number of early diagnostic procedures. In addition, the rise in government initiatives to control the healthcare burden and growing healthcare awareness among people drive market growth. However, some of the restraints in the market including the high cost of kits and lack of trained professionals are impeding the growth of this market all over the world.

Based on the type, the cell proliferation kit market is segmented into fluorometric cell viability kits, colorimetric cell viability kits, bioluminescent cell viability kits, and others. The colorimetric cell viability kits segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. This method for detecting cell viability is cost-effective and easy to retrieve throughout data. It is also anticipated that the widespread use of this technique to identify various cellular activities, such as DNA synthesis, metabolic activity, and ATP production, will spur the expansion of the future market segment.

Based on the application, the market is fragmented into pharmaceutical and biotechnology companies, academic institutes and research laboratories, and others. The pharmaceutical and biotechnology companies segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Cell proliferation kits are used in academic institutions and research labs to identify cell damage by monitoring how the cells respond to various stimuli, such as hydrogen peroxide, antibiotics, etc.

For a better understanding of the market adoption of the cell proliferation kit, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the cell proliferation kit industry owing to the growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region. For instance, according to the centers for Medicare & Medicaid services, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 18.3%.

Some of the major players operating in the market include: Thermo Fisher Scientific Inc, Merck KGaA, GE Healthcare, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Becton Dickinson and Co, Biotium, Agilent Technologies Inc, F. Hoffmann-La Roche AG, and Biological Industries, among others. Several M&As along with partnerships have been undertaken.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Cell Proliferation Kit Market
  • 2.2. Research Methodology of the Cell Proliferation Kit Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CELL PROLIFERATION KIT MARKET

6 GLOBAL CELL PROLIFERATION KIT MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Fluorometric Cell Viability Kits
  • 7.2. Colorimetric Cell Viability Kits
  • 7.3. Bioluminescent Cell Viability Kits
  • 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Pharmaceutical and Biotechnology Companies
  • 8.2. Academic Institutes and Research Laboratories
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1 NORTH AMERICA CELL PROLIFERATION KIT MARKET
    • 9.1.1 U.S.
    • 9.1.2 Canada
    • 9.1.3 Rest of North America
  • 9.2 EUROPE CELL PROLIFERATION KIT MARKET
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 U.K.
    • 9.2.4 Spain
    • 9.2.5 Italy
    • 9.2.6 Rest of Europe
  • 9.3 ASIA PACIFIC CELL PROLIFERATION KIT MARKET
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4. Australia
    • 9.3.4 Rest of Asia Pacific
  • 9.4 REST OF WORLD CELL PROLIFERATION KIT MARKET

10 CELL PROLIFERATION KIT MARKET DYNAMICS

  • 10.1 Market Drivers
  • 10.2 Market Challenges
  • 10.3 Impact Analysis

11 CELL PROLIFERATION KIT MARKET OPPORTUNITIES

12 CELL PROLIFERATION KIT MARKET TRENDS & INSIGHTS

13 DEMAND AND SUPPLY SIDE ANALYSIS

  • 13.1 Demand Side Analysis
  • 13.2 Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Thermo Fisher Scientific Inc
  • 18.2. Merck KGaA
  • 18.3. GE Healthcare
  • 18.4. PerkinElmer Inc
  • 18.5. Bio-Rad Laboratories, Inc.
  • 18.6. Becton Dickinson and Co
  • 18.7. Biotium
  • 18.8. Agilent Technologies Inc
  • 18.9. F. Hoffmann-La Roche AG
  • 18.10. Biological Industries

19 DISCLAIMER